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ABSTRACT 
Infectious bronchitis (IB) is an important poultry disease caused by a coronavirus named 
Infectious Bronchitis Virus (IBV). Failure of protection as well as variation on clinical 
manifestations associated with the emergence of many different antigenic types of the IBV 
have been reported in the last years. Although vaccines may protect against heterologous 
strains, it has been speculated that the vaccine serotype Massachusetts has not always been 
able to confer full protection against some field strains of IBV. In this study, multiple tests 
were performed in order to evaluate the protective potential of a commercial vaccine against 
four strains IBV previously classified as variants by sequencing, phylogenetic and pathogenic 
analyses. Seven day-old chicks were vaccinated with H120 vaccine strain by eyedrop and 
challenged with field IBV strains (BIBR116, 438, 1496 and 212). Degrees of ciliary activity 
were measured at 5 days after challenge to assess the ability of the vaccine to protect the 
chicks. In two vaccinated groups and challenged with variants strains (BIBR116 and 
BIBR212), a dose of 103.5EID50/bird H120 vaccine (serotype Massachusetts) was able to 
induce protection to the respiratory tract, demonstrating good cross-protection of the vaccine 
against the field strains. However, in other two groups (strains BIBR438 and BIBR1496), the 
challenge failed, despite the accurate titration and previous pathotyping assay that had proven 
that the challenge virus was pathogenic. These results suggest that the infectivity of IBV was 
reduced from the time it was prepared until the moment of inoculating the chickens. This 
reinforces the knowledge of the high liability of IBV and thus the importance of care on 
handling the vaccine during vaccination to ensure a good immunity. 
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INTRODUCTION 
Infectious bronchitis (IB) remains one of the main diseases causing economic losses in 
commercial poultry due to respiratory, renal, reproductive disease, and more recently also 
associated with enteric problems (Villarreal et al., 2007, Cavanagh and Gelb, 2008). 
Infectious bronchitis is often controlled with vaccines. However, due to the different clinical 
manifestations and the high frequency of mutation in the viral genome (RNA single-stranded 
non-segmented), this virus has been associated with failure of vaccine cross protection 
(Picault et al., 2003, Wang et al., 1994). The concept of protectotypes has been suggested to 
be a valuable one to consider in terms of developing strategies to control IBV infection, since 
it provides direct information about the efficacy of a vaccine (Cook at al., 1999). Strains that 
induce protection to each other belong to the same protectotype. Within this concept, this 
study evaluated four field strains of IB genotypically classified as variants of the 
Massachusetts serotype vaccine strain.  
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MATERIALS AND METHODS 
The field strains of IBV were recovered from birds with respiratory signs, and drop in egg 
production. Samples were insolated in SPF fertile eggs (OIE, 2008). After viral isolation, the 
extraction of viral RNA was obtained using standard methodology (Trizol, Gibco/BRL) 
according to manufacturer's instructions. The synthesis of complementary DNA (cDNA) was 
performed using the enzyme reverse transcriptase (Super Script II, Invitrogen) and the primer 
reverse S1 3'. After the production of cDNA, the amplification of the target region was 
performed as described in Kwon et al., 1993. The samples confirmed as positive in RT-PCR 
were subjected to DNA sequencing and analysis to distinguish between classical strain like 
Massachusetts serotype and variant strains using the system "BigDyeTM terminator - cycle 
sequencing ready reaction - Applied Biosystems' (Perkin Elmer) v. 3.0 in automated DNA 
sequencer ABI 3130. Sequences were aligned by using the Clustal W programs (Thompson et 
al., 1991) compared to other sequences available in Genbank. Phylogenetic analysis was 
performed using the software MEGA version 5 (Kumar et al., 2004). The obtained sequence 
data were used for the construction of a phylogenetic tree. The alignment of the nucleic acid 
sequences was used to calculate a distance of Massachusetts serotype to the field strains. Four 
strains that were farthest from the Massachusetts serotype and the H120 vaccine strain were 
titrated and diluted to 103.5EID50/bird for the in vivo protection studies (assay to define 
protectotypes). The study was approved by the Ethics Committee on Use of Animals in 
Experiments (ECUAE) of Embrapa Swine and Poultry. . Sixty-eight one day-old chicks, 
derived from a specific pathogen free (SPF) flock of White Leghorn parents, were randomly 
divided into 4 groups of 14 and 4 groups of 3 chicks, respectively. All birds were maintained 
in poultry isolator units with filtered air and positive pressure. The groups of 14 chicks 
received a dose of H120 vaccine by eyedrop at 1-week-old (vaccinated groups). The groups 
of 3 chicks were not vaccinated. After 4 weeks, one bird of each group of vaccinated birds, 
was euthanized to perform the ciliary beat evaluation test. After confirming the ciliary 
activity, each IBV field strain (BIBR116, 438, 1496 and 212) was inoculated by eyedrop in 
the two previously groups: vaccinated and non-vaccinated.Five days post-challenge, tracheas 
of all groups were carefully removed and examined for ciliostasis test. Briefly, the parameter 
for the ciliostasis test are described as follow: 0) all cilia are beating vigorously; 1) all cilia 
are beating slowly; 2) some cilia are beating very slowly; and 3) no cilia are beating (Trevisol 
et al., 2011). The response of individual birds on the tracheal ciliostasis test was qualified in: 
a. protected bird (when the median of the results was ≤ 1) or b. not protected bird (when the 
median of the results was ≥ 2). To validate the in vivo vaccine protection study, at least 90% 
of the challenged vaccinated birds should have no evidence of IBV in their trachea (degrees 
zero to one), while 90% or more of the control birds (only challenged) should have evidence 
of the presence of the virus (degrees 2 to 3). 
 
RESULTS AND DISCUSSION  
The tracheas of vaccinated groups (one bird/group) that were evaluated before challenge had 
100%  ciliary activity. The post-challenged results from all groups are summarized in Table 
1. The challenge was satisfactory in 2 groups (BIBR116 and BIBR212 field strains), with 
100% of birds evidencing the presence of the virus, confirming the pathogenicity of these 
strains. Vaccinated groups and post-challenged with BIBR116 and BIBR212 field strains had 
satisfactory results, with 100% of birds without evidence of IBV in the trachea. The field 
strains BIBR438 and BIBR1496 failed to induce ciliostasis. The most likely explanation for 
this finding is the reduction or loss of viral infectivity of these two strains due to  delay in the 
procedures of handling and inoculation, despite the accurate titration and previous in vivo 
pathogenic studies that had proved that the challenged viruses of these groups were 
pathogenic. This finding confirms the fragility of IBV and careful handling of the samples 
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should be followed while vaccinating birds in both research and routine activities in a 
hatchery or farm,. |Then, for these two samples (BIBR438 and BIBR1496 strains), the assay 
of vaccine protection was disregarded. The overall results of this study agree with a previous 
study in which birds that follow the precepts of an appropriate vaccination, respond well to 
challenges, even against samples considered variants (Trevisol et al., 2010), promoting cross-
protection. However, other studies argue that there is failure on vaccine protection using only 
serotype Massachusetts vaccine. Additional data on microscopic lesions and viral recovery 
are underway to complement this study. The in vivo assay to define protectotypes has shown 
the effectiveness of the vaccine Massachusetts H120, although they are still few Brazilian 
samples classified as protectotypes. 
 
Table 1. Results of challenge assay in which chickens were vaccinated with H120 
Massachusetts Holland serotype  at 7 day-old and after 4 weeks were challenged with 
heterologous virus. 
Groups Number of birds/ 
ciliary activity score 
% of ciliary activity 
zero to one 2 to 3 
 0 1 2 3   
NVC116 0/3 0/3 1/3 2 0 100 
NVC438 0/3 3/3 0/3 0/3 100 0 
NVC1496 0/3 3/3 0/3 0/3 100 0 
NVC212 0/3 0/3 0/3 3 0 100 
VC116 6/13 7/13 0/13 0/13 100 0 
VC438 5/14 6/14 3/14 0/14 78.5 21.5 
VC1496 11/14 2/14 1/14 0/14 92.8 7.2 
VC212 7/13 6/13 0/13 0/13 100 0 
NVC: non-vaccinated and challenged; VC: vaccinated and challenged. 
 
CONCLUSION 
Field observations have suggested that the only serotype IBV live vaccine used to control IB 
in Brazil (H120 Massachusetts Holland serotype) does not full protect the birds. However, 
this study has shown that one single dose of 103.5EID50/bird H120 vaccine was able to induce 
full protection against BIBR212 and BIBR116 field strains. These results reinforce the 
importance in classifying the new field strains in protectotypes, before changing strategies on 
controlling this disease. This study also demonstrated the fragility of the IBV, reinforcing 
careful handling of live samples, including the vaccine. 
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